J. Crowley

580 total citations
6 papers, 429 citations indexed

About

J. Crowley is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J. Crowley has authored 6 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in J. Crowley's work include Psoriasis: Treatment and Pathogenesis (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). J. Crowley is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). J. Crowley collaborates with scholars based in United States, United Kingdom and Canada. J. Crowley's co-authors include A.B. Gottlieb, Melinda Gooderham, Yves Poulin, Giampiero Girolomoni, C. Paul, Jennifer Clay Cather, ChiaChi Hu, Kara N. Shah, Ulrich Mrowietz and Denise K. Reinke and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and British Journal of Dermatology.

In The Last Decade

J. Crowley

6 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Crowley United States	5	303	158	80	69	66	6	429
Álvaro González‐Cantero Spain	12	215 0.7×	79 0.5×	50 0.6×	45 0.7×	46 0.7×	48	375
Jonathan H. Chung United States	9	265 0.9×	60 0.4×	123 1.5×	71 1.0×	56 0.8×	18	478
Tai‐Ming Ko Taiwan	9	91 0.3×	45 0.3×	92 1.1×	60 0.9×	38 0.6×	22	406
Ella A.M. van der Voort Netherlands	5	277 0.9×	101 0.6×	92 1.1×	55 0.8×	41 0.6×	5	388
Clinton C. Bertram United States	10	119 0.4×	21 0.1×	109 1.4×	109 1.6×	26 0.4×	14	365
S. von Schmiedeberg Germany	9	43 0.1×	54 0.3×	65 0.8×	38 0.6×	27 0.4×	15	271
Meng Chai China	12	167 0.6×	22 0.1×	20 0.3×	181 2.6×	38 0.6×	25	537
Joseph J. Moellman United States	11	103 0.3×	38 0.2×	178 2.2×	27 0.4×	26 0.4×	19	438
Jūratė Kondrackienė Lithuania	10	41 0.1×	125 0.8×	63 0.8×	81 1.2×	30 0.5×	13	818
Melinda Zsuzsanna Szabó Hungary	11	187 0.6×	13 0.1×	200 2.5×	76 1.1×	11 0.2×	26	460

Countries citing papers authored by J. Crowley

Since Specialization

Citations

This map shows the geographic impact of J. Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Crowley more than expected).

Fields of papers citing papers by J. Crowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Crowley. The network helps show where J. Crowley may publish in the future.

Co-authorship network of co-authors of J. Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of J. Crowley. A scholar is included among the top collaborators of J. Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Crowley. J. Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Armstrong, April W., Emily Edson‐Heredia, Baojin Zhu, et al.. (2022). Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey. Advances in Therapy. 39(6). 2657–2667. 8 indexed citations

Yamauchi, Paul S., J. Crowley, Primal Kaur, Lynda Spelman, & Richard B. Warren. (2018). Biosimilars: what the dermatologist should know. Journal of the European Academy of Dermatology and Venereology. 32(7). 1066–1074. 5 indexed citations

Paul, C., Jennifer Clay Cather, Melinda Gooderham, et al.. (2015). Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2). British Journal of Dermatology. 173(6). 1387–1399. 350 indexed citations

Papp, Kim, J. Crowley, C. Paul, et al.. (2015). THU0413 Apremilast, An Oral Phosphodiesterase 4 Inhibitor: Improvements in Nail and Scalp Psoriasis and Psoriasis Area and Severity Index in Patients with Moderate to Severe Plaque Psoriasis (Esteem 1 and 2). Annals of the Rheumatic Diseases. 74. 347–347. 1 indexed citations

Pappo, Alberto S., J. Crowley, Denise K. Reinke, et al.. (2010). Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.. Journal of Clinical Oncology. 28(15_suppl). 10000–10000. 37 indexed citations

Pappo, Alberto S., J. Crowley, Denise K. Reinke, et al.. (2009). A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas. Journal of Clinical Oncology. 27(15_suppl). 10503–10503. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact